Evidence map›Paper›PMID 33988992›Full record

ArticleJournal of medicinal chemistry2021

Starving Bacteria of Iron: A Potential Strategy to Disperse Bacterial Biofilms.

George A Naclerio, Herman O Sintim

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

George A NaclerioChemistry Department, Institute for Drug Discovery, Purdue University, West Lafayette, Indiana 47907, United States.
Herman O SintimChemistry Department, Institute for Drug Discovery, Purdue University, West Lafayette, Indiana 47907, United States.ORCID 0000-0002-2280-9359

Funding

Drug Discovery in Infectious Disease TrainingT32AI148103 · NIAID · PURDUE UNIVERSITY · PI STAHELIN, ROBERT VIRGIL, YEO, YOON · 2020 to 2024
$949k
NIAID NIH HHS T32 AI148103
6 · The paper itself

Abstract

Halogenated phenazines (HPs) are potent antimicrobial agents. A newly developed halogenated phenazine, HP-

Indexed as

AnimalsAnti-Bacterial AgentsBiofilmsChelating AgentsDisease Models, AnimalHalogenationIronMethicillin-Resistant Staphylococcus aureusMiceMicrobial Sensitivity TestsPhenazinesStaphylococcal InfectionsAnti-Bacterial AgentsChelating AgentsIronphenazinePhenazines

Identifiers

PMID33988992
PMCPMC9110258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.